BIO-key International, Inc.
BKYI
$4.55
-$0.09-2.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.89% | -14.32% | -13.39% | -0.77% | -18.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.89% | -14.32% | -13.39% | -0.77% | -18.02% |
| Cost of Revenue | 15.80% | 6.49% | -53.72% | -62.84% | -76.06% |
| Gross Profit | -1.58% | -19.07% | 13.98% | 81.00% | 107.65% |
| SG&A Expenses | -7.58% | -12.02% | -14.75% | -13.90% | -12.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.69% | -6.17% | -20.06% | -24.13% | -31.51% |
| Operating Income | 7.19% | -7.89% | 28.95% | 47.86% | 45.32% |
| Income Before Tax | -45.27% | -65.16% | 23.17% | 39.23% | 39.15% |
| Income Tax Expenses | 171.74% | 171.74% | 91.69% | 91.70% | 82.84% |
| Earnings from Continuing Operations | -46.38% | -66.43% | 19.59% | 36.95% | 38.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.38% | -66.43% | 19.59% | 36.95% | 38.36% |
| EBIT | 7.19% | -7.89% | 28.95% | 47.86% | 45.32% |
| EBITDA | 6.09% | -10.04% | 29.63% | 50.42% | 47.50% |
| EPS Basic | 58.72% | 55.44% | 84.45% | 86.62% | 84.21% |
| Normalized Basic EPS | 72.32% | 68.05% | 86.13% | 88.00% | 85.05% |
| EPS Diluted | 58.72% | 55.44% | 84.45% | 86.62% | 84.21% |
| Normalized Diluted EPS | 72.32% | 68.05% | 86.13% | 88.00% | 85.05% |
| Average Basic Shares Outstanding | 183.99% | 222.01% | 253.45% | 252.63% | 244.75% |
| Average Diluted Shares Outstanding | 183.99% | 222.01% | 253.45% | 252.63% | 244.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |